Skip to main content
Caplight Logo









VAXDIGM

VAXDIGM

Private
SeoulEnterprise Softwarehttps://vaxdigm.com/

Last Round

Grant

May 20, 2026

Total Funding Raised

$3.98M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

VAXDIGM is a biotechnology company that develops innovative vaccines using its proprietary CHAPERNA (Chaperone + RNA) platform technology.

Sector

Enterprise Software

Verticals

Workflow Automation, Project Management

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

vaccine developmentbiotechnologyprotein engineeringsynthetic antigenbiomaterialsbiotech startupresearch and developmentR&Dmicrobial protein productioninfectious disease researchdrug discoverybiopharmagovernment research grantsvaccine platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VAXDIGM Comparables

Compare VAXDIGM with similar companies based on industry and business-model similarity.

No public comparables are available for VAXDIGM. Request access to learn about comparables coverage.

Request access

VAXDIGM Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 20, 2026
GrantDec 1, 2025
Series AOct 24, 2024
Pre SeedAug 1, 2023
SeedMay 1, 2022

Key People

Founding team and executive leadership

SungJae Kim

CEO 대표이사

Executive Team

VAXDIGM Investors

Notable investors and investment history

VAXDIGM investors
InvestorRounds
Korea Alternative Investment Asset ManagementSeries A
Infobank CorpSeries A
The Invention LabSeries A
LITALCOSeries A
New Paradigm InvestmentSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Raised $1.11M in grant funding.

  • Dec 1, 2025

    $520K raised in Grant round

VAXDIGM Filings

Explore SEC and related filing metadata, where available.

VAXDIGM filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about VAXDIGM's valuation, stock price, and market status.

Is VAXDIGM a public or private company?

VAXDIGM is a private company.

What is the current stock price of VAXDIGM?

VAXDIGM is a private company with no public stock price. Caplight tracks VAXDIGM's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is VAXDIGM worth (valuation)?

Valuation information for VAXDIGM is not publicly available.

Can I buy VAXDIGM stock?

VAXDIGM shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was VAXDIGM's last funding round?

VAXDIGM's most recent funding round was Grant on May 20, 2026.

Who are the main investors in VAXDIGM?

Key investors in VAXDIGM include Korea Alternative Investment Asset Management, Infobank Corp, The Invention Lab, LITALCO, New Paradigm Investment.

Will VAXDIGM IPO soon?

No public IPO plans have been announced for VAXDIGM.

How can I track VAXDIGM secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VAXDIGM's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range3
Year Founded2021
Last FundingMay 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?